Top stories

View all news

18 October 2021

First Portuguese COVAX doses reach Senegal

As part of a pledge to share at least 5% of domestic supply of vaccines with its development partners, the first doses donated by Portugal through COVAX have reached Senegal.

11 October 2021

Vigne des Nations: 2020 vintage awarded to Gavi by Geneva Canton, for its action for global health

This Monday morning, 11 October, Mr Serge Dal Busco, President of the Council of State of Geneva, symbolically awarded the parcel of the Vigne des Nations to Gavi, the Vaccine Alliance. This recognition honours the commitment of this organisation…

11 October 2021

First Swiss-donated doses ship to Sierra Leone, as part of 4 million dose pledge

The first shipment of a Swiss donation of 4 million doses has arrived in Sierra Leone, with 24,000 doses of the AstraZeneca vaccine touching down in Freetown on 9 October 2021.

COVAX vaccine roll-out

>406 million COVAX vaccines shipped
OWP
144 participants

As of 25 Oct 2021

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

Learn more

The COVID-19 vaccine race

Pre-clinical
194vaccines
are being explored in lab experiments and animals
PHASE 1
34 vaccines
are undergoing safety tests in healthy young individuals
Phase 2
45vaccines
are being tested in broader groups of people
Phase 3
37vaccines
are in large international trials to test their impact on COVID-19
IN USE
21vaccines
are currently being offered to the general population
Phase 4
10vaccines
are being monitored in the wider population after being approved

Source: WHO

Learn more

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

#VaccinesWork

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Top VaccinesWork stories

View all stories

26 October 2021

Vaccine Ambassadors: The race to vaccinate Cameroon’s school communities

Cameroon is considering taking COVID-19 vaccines to schools amid a rise in the number of new cases.

26 October 2021

Towards universal coverage of maternal health services in Tajikistan

Nozanin is a secondary school teacher and lives in the relatively prosperous region of Sughd, with better access to maternal health services than is found in other regions. However, medical costs are excessive for most people in the country,…

26 October 2021

Are COVID-19 vaccines safe for teenagers and children?

Some countries are already offering COVID-19 vaccines to teenagers and may expand this to children in the near future. Here’s what we know about vaccine safety and efficacy in these groups.

Supported countries

Supported Countries

Our impact

Syringe >822 million children immunised
First aid locator >14 million future deaths prevented
Transitioned 16 countries transitioned from Gavi support
Billions >150 US$ billion in economic benefits for countries (2000–2017)
Children 85% of the world's children reached by routine immunisation

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Like. Follow. Share.

    Subscribe to our newsletter